Advertisement
UK markets close in 7 hours 12 minutes
  • FTSE 100

    8,284.73
    +71.24 (+0.87%)
     
  • FTSE 250

    20,355.16
    +190.62 (+0.95%)
     
  • AIM

    776.41
    +4.88 (+0.63%)
     
  • GBP/EUR

    1.1650
    -0.0010 (-0.08%)
     
  • GBP/USD

    1.2535
    -0.0029 (-0.23%)
     
  • Bitcoin GBP

    50,883.14
    -599.05 (-1.16%)
     
  • CMC Crypto 200

    1,369.13
    +4.01 (+0.29%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.72
    +0.24 (+0.31%)
     
  • GOLD FUTURES

    2,326.50
    -4.70 (-0.20%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,467.17
    -111.13 (-0.60%)
     
  • DAX

    18,232.61
    +57.40 (+0.32%)
     
  • CAC 40

    8,014.36
    +17.72 (+0.22%)
     

If You Had Bought Teladoc Health (NYSE:TDOC) Stock Three Years Ago, You Could Pocket A 279% Gain Today

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. To wit, the Teladoc Health, Inc. (NYSE:TDOC) share price has flown 279% in the last three years. How nice for those who held the stock! And in the last month, the share price has gained -3.2%.

View our latest analysis for Teladoc Health

Given that Teladoc Health didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

ADVERTISEMENT

In the last 3 years Teladoc Health saw its revenue grow at 54% per year. That's much better than most loss-making companies. Along the way, the share price gained 56% per year, a solid pop by our standards. This suggests the market has recognized the progress the business has made, at least to a significant degree. That's not to say we think the share price is too high. In fact, it might be worth keeping an eye on this one.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

NYSE:TDOC Income Statement, October 1st 2019
NYSE:TDOC Income Statement, October 1st 2019

Teladoc Health is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. So it makes a lot of sense to check out what analysts think Teladoc Health will earn in the future (free analyst consensus estimates)

A Different Perspective

Teladoc Health shareholders are down 16% for the year, but the broader market is up 1.2%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Investors are up over three years, booking 56% per year, much better than the more recent returns. Sometimes when a good quality long term winner has a weak period, it's turns out to be an opportunity, but you really need to be sure that the quality is there. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling.

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.